TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Edwards Lifesciences Nordic AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
349,007
|
329,405
|
326,923 |
| Financial expenses |
1,332
|
696
|
434 |
| Earnings before taxes |
13,806
|
16,204
|
11,113 |
| EBITDA |
15,056
|
16,952
|
11,736 |
| Total assets |
109,998
|
119,149
|
112,721 |
| Current assets |
109,508
|
118,856
|
112,226 |
| Current liabilities |
49,280
|
68,238
|
69,917 |
| Equity capital |
58,460
|
48,613
|
37,597 |
| - share capital |
67
|
67
|
73 |
| Employees (average) |
36
|
31
|
34 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
53.1%
|
40.8%
|
33.4% |
| Turnover per employee |
9,695
|
10,626
|
9,615 |
| Profit as a percentage of turnover |
4.0%
|
4.9%
|
3.4% |
| Return on assets (ROA) |
13.8%
|
14.2%
|
10.2% |
| Current ratio |
222.2%
|
174.2%
|
160.5% |
| Return on equity (ROE) |
23.6%
|
33.3%
|
29.6% |
| Change turnover |
17,906
|
28,963
|
13,916 |
| Change turnover % |
5%
|
10%
|
4% |
| Chg. No. of employees |
5
|
-3
|
0 |
| Chg. No. of employees % |
16%
|
-9%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.